PP
GEVA

Paloma Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Paloma Partners’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,400
Closed -$332K – 2078
2015
Q1 		$332K Sell
3,400
-226
-6% -$23.9K 0.01% 920
2014
Q4 		$337K Buy
+3,626
New +$286K 0.01% 811

Paloma Partners's GEVA Position: Q2 2015 in Review

Paloma Partners sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,400 shares — an estimated $332K sold.

Paloma Partners first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $337K in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Paloma Partners reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Paloma Partners sold 3,400 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $332K.
  • Paloma Partners first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Paloma Partners's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $337K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Paloma Partners's 13F filing for Q2 2015, filed 14 Aug 2015.